Powered By BIOCARTA Europe GmbH Borsteler Chaussee 53, D-22453 Hamburg Germany Tel +49-40-5257030 Fax +49-40-52570377 info.de@biocarta.com CD31 (PECAM-1) Concentrated Monoclonal Antibody Cat: # CM131A: 0.1 ml, Cat: #CM131D: 0.25 ml, Cat: #CM131B: 0.5 ml Specificity and Comments: Second Post-Pretreatment (Optional) CD31 recognizes a 100kDA glycoprotein in endothelial cells and 130kD in platelets. It reacts weakly with mantle zone B-cells, peripheral T-cells, and neutrophils. CD31 can detect vascular endothelium associated antigen and has been used as a marker for benign and malignant human vascular disorders, myeloid leukemia infiltrates and megakaryocytes in normal bone marrow. When compared to Factor VIII and CD34 antibodies, studies have shown CD31 to be a superior marker for angiogenesis. CD31 has been used to measure angiogenesis, which reportedly predicts tumor recurrence. CD31 used in a panel with CD34 and Factor VIII has also been used to mark Kaposi’s sarcoma and angiosarcomas. Other studies have also indicated that CD31 and CD34 can be used as markers for myeloid progenitor cells that recognize different subsets of myeloid leukemia infiltrates (granular sarcomas). If tissues are overfixed, apply cold pepsin for 1 minute and wash in DI water. Species Reactivity: Human; other not tested. Clone: JC/70A Isotype: IgG1/ Known Applications: Immunohistochemistry (frozen /formalin-fixed paraffin-embedded tissues) Positive Control: Tonsil or angiosarcoma Cellular Localization: Cytoplasmic and membrane Supplied As: PBS, pH 7.4 with carrier protein and preservative Protein Block Incubate for 5 minutes at room temperature (RT) with BIOCARE’S BACKGROUNDERASER. Primary Antibody Dilute 1:25-1:50. Incubate for 30-120 minutes at RT. Biotinylated Secondary Antibody Incubate for 10-20 minutes at RT. Enzyme Labeled Streptavidin Incubate for 10-20 minutes at RT with BIOCARE’S 4plus Detection System. Chromogen Incubate for 5-10 minutes. Use BIOCARE’S CHROMOGENCARE. For additional enhancement, apply BIOCARE’S DABSPARKLE for 1 minute. Technical Notes NUCLEARDECLOAKER is a potent agent for epitope retrieval and tissues may be 4 to 10 times more sensitive to immunohistochemical staining. Certain tissues may express nonspecific background staining due to endogenous biotin. Blocking of endogenous biotin can be quenched by using BIOCARE’S AvidinBiotin Blocking Kit (Cat. #AB972G). Endogenous Peroxidase Block Positive-charged slides for tissue adhesion should be used for heatinduced epitope retrieval methods. Do not use adhesives in the water bath. Dry slides at 25C overnight and then dry for 10-30 minutes at 60 C. Be sure that all water is removed from the tissue. Use BIOCARE’S KLING-ON Slides and Desert Chamber Drying Oven. If using an HRP system, block for 5 minutes with BIOCARE’S PEROXIDAZED 1. Protocol Notes Protocol Recommendations: Pretreatment (Required) Gently boil tissue sections (100C) for 20 minutes in NUCLEARDECLOAKER. Allow the solution to cool for 20 minutes. Alternatively, steam tissue sections for 45-60 minutes, or use a pressure cooker for 2-5 minutes (BIOCARE’S Decloaking Chamber). For Research use only. Not for therapeutic or in vitro diagnostic use. Revised 2/12/16 The optimum antibody dilution and protocols for a specific application can vary due to many factors. These include, but are not limited to: fixation, incubation times, tissue section thickness and detection kit used. The data sheet’s recommendations and protocols are based on exclusive use of BIOCARE products. Due to the superior sensitivity of these unique reagents, the recommended incubation times and titers listed are not applicable to other detection - Page 1 - systems, as results may vary. Ultimately, it is the responsibility of the investigator to determine optimal conditions. Limitations and Warranty This antibody is available for research use only. It is not approved for use in humans or in clinical diagnosis. There are no warranties, expressed or implied, which extend beyond this description. BIOCARE is not liable for property damage, personal injury, or economic loss caused by this product. References: 1. 2. 3. 4. 5. 6. 7. Govender D, Harilal P, Dada M, Chetty R. CD31 (JC70) expression in plasma cells: an immunohistochemical analysis of reactive and neoplastic plasma cells. J Clin Pathol 1997 Jun;50(6):490-3 Rongioletti F et al. Tumor vascularity as a prognostic indicator in intermediate-thickness (0.76-4 mm) cutaneous melanoma. A quantitative assay. Am J Dermatopathol 1996 Oct;18(5):474-7. Engel CJ, Bennett ST et al.. Tumor angiogenesis predicts recurrence in invasive colorectal cancer when controlled for Dukes staging. Am J Surg Pathol 1996 Oct;20(10):1260-5. Russell Jones R et al. Staining for CD31 and CD34 in Kaposi sarcoma. Virchows Arch 1996 Jul;428(4-5):217-21. Poblet E et al. Different immunoreactivity of endothelial markers in well and poorly differentiated areas of angiosarcomas. J Clin Pathol 1995 Nov;48(11):1011-6. Hudock J, Chatten J, Miettinen M. Immunohistochemical evaluation of myeloid leukemia infiltrates (granulocytic sarcomas) in formaldehyde-fixed, paraffin-embedded tissue. Am J Clin Pathol. 1994 Jul;102(1):55-60. Parums DV, Mason DY et al. JC70: a new monoclonal antibody that detects vascular endothelium associated antigen on routinely processed tissue sections. J Clin Pathol 1990 Sep;43(9):752-7. BIOCARE Products Catalog # Size Product Description CB911M 500ml NULCEARDECLOAKER Assure Technology A 10X Tris buffer formulation, pH 9.5. Unmasks or decloaks epitopes crosslinked by formalin fixation (Color-coded with pH indicator) DC2000 1 each Decloaking Chamber Electric pressure cooker for HIER methods (Superior to microwave methods) PD900L 100ml IgGCARE Color-coded antibody diluent for primary antibodies PEP956H 25ml CAREZYME II (Pepsin) Liquid, ready-to-use. Reagent for digestion techniques. DRY2000 1 each Desert Chamber Drying oven with turbo fan and temperature alarm system DS830H 25ml DABSPARKLE DAB enhancing solution SFH1104A 1 gross Kling-ON HIER Slides Positive-charged slides for HIER methods (Extra strong) For Research use only. Not for therapeutic or in vitro diagnostic use. Revised 2/12/16 - Page 2 -